Project REMAP-CAP – Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia

Basic data

Acronym:
REMAP-CAP
Title:
Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia
Duration:
17/11/2020 to 31/12/2023
Abstract / short description:
The purpose of this study is to evaluate the effect of a series of interventions to improve outcomes in adult patients with severe community-acquired pneumonia (CAP) admitted to an intensive care unit.
Keywords:
community-acquired pneumonia, adaptive platform trial

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen

Local organizational units

Internal Medicine Department I
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

Help

will be deleted permanently. This cannot be undone.